Skip to main content

Syncona

data as at: 06/04/2020
ObjectiveTo deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Management groupSyncona Investment Managers
AIC sectorBiotechnology & Healthcare

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

This company is not currently a member of the AIC.  We are therefore unable to provide full company information at this time.

Data provided by Morningstar.